Rocco Amendolara | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study	DIABETES, OBESITY AND METABOLISM	2024
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes	EXPERT OPINION ON INVESTIGATIONAL DRUGS	2024
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study	CLINICAL THERAPEUTICS	2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes	DIABETES/METABOLISM RESEARCH AND REVIEWS	2023
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I	DIABETES/METABOLISM RESEARCH AND REVIEWS	2022
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis	INTERNAL AND EMERGENCY MEDICINE	2021